Published • loading... • Updated
Slimming Pens Start to Reach SUS; See Cities
Summary by A TARDE
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Drugs used in the treatment of obesity, such as semaglutide and tirzepatide, began to be offered by Brazilian municipalities even before an official incorporation into the Unified Health System (SUS). Movement has provoked debates about costs, priorities in public health and inequality in access to new technologies.The advance gained strength after the City of Rio de Janeiro invest in the purchase of semaglutide for distribution in the municipal…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
